The European Commission has approved Sanofi and Regeneron’s Praluent for reducing cardiovascular ... who recently demonstrated that their daily pill bempedoic acid can significantly lower ...
Regeneron Pharmaceuticals (NASDAQ:REGN) has received approval from the U.S. Food & Drug Administration (FDA) for its Praluent (alirocumab) injection to treat children with genetic form of high ...